Selahattin Akar, Nilgun Karadag, Tulin Gokmen Yildirim, Handan Hakyemez Toptan, Emre Dincer, Abdulhamit Tuten, Taner Yavuz, Sevilay Topcuoglu, Hande Ozgun Karatepe, Elif Ozalkaya, Guner Karatekin, Fahri Ovali
OBJECTIVE: The aim of this study is to evaluate whether the platelet mass in the first 24 h of life is effective on closure of patent ductus arteriosus (PDA) or not. STUDY DESIGN: Preterm infants with a gestational age of < 32 weeks, hospitalized at a tertiary neonatal intensive care unit (NICU) and requiring medical treatment (intravenous or oral ibuprofen) for hemodinamically significant PDA (hsPDA) were enrolled in this study. The patients were divided into two groups after first course of pharmacologic treatment according to closure of PDA (Group 1: PDA closure, Group 2: PDA without closure)...
December 2016: Journal of Maternal-fetal & Neonatal Medicine